Navigation Links
Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
Date:1/29/2008

Athletes Using Surgex(TM) can be Assured of No Banned Substances

BASKING RIDGE, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), announced today that Surgex(TM) (http://www.surgexsports.com) has been tested and certified into the Banned Substance Control Group's (BSCG) certification program. This is the only certification program in the US that uses a World Anti Doping Agency accredited laboratory to detect for dangerous banned substances in nutritional supplements. Each batch of Millennium's line of Surgex(TM) products are now tested and certified not to contain substances such as hormones, steroids, stimulants, diuretics, etc that are banned for Professional, Collegiate and Olympic sports. The BSCG certification in addition to the Surgex'(TM) clinical trials should provide the product a competitive advantage upon commercialization into the billion dollar sports nutritional supplement marketplace.

"The athlete can now be assured that our Surgex(TM) line of products can be safely consumed as each batch is tested for a list of substances that are banned by organizations such as the International Olympic Committee (IOC), the World Anti-Doping Agency (WADA), the United States Anti-Doping Agency (USADA), the National Collegiate Athletic Association (NCAA), the National Football League (NFL), and many other professional and amateur sports leagues." states Carl Germano, RD, CNS, CDN, clinical nutritionist and VP of Research & product Development for Millennium Biotechnologies.

With over 5 years in the medical market as a nutritional adjunct to medical care for immuno-compromised conditions and several successful studies including 2 double blind, placebo controlled trials in Division 1 athletes, the Surgex(TM) line of products is breaking new ground for credibility and pro
'/>"/>

SOURCE Millennium Biotechnologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
4. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
5. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
7. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
8. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/17/2014)... PCCA received the Autism Hope Alliance,s ... program seal for best practices in meeting needs ... practices, materials and goods that meet strict criteria ... affected by autism often have unique physical or ... found in food and medicine – for instance ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 30, 2011 Unilife Corporation ("Unilife" or the "Company") ... its preliminary financial results for the fourth quarter and ... Corporate Highlights: Completed construction of new ... and successfully relocated entire staff (December 2010) Appointed ...
... Aug. 30, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Paul Bisaro, Watson,s President and Chief Executive Officer, will provide ... 2011 Morgan Stanley Global Healthcare Conference on Tuesday, September 13, ... New York in New York City. The presentation will be ...
Cached Medicine Technology:Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 2Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 3Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 4Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 5Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 6Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 7Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 8Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 9Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 10
(Date:12/21/2014)... AngelWeddingDress.com’s new collection of 2015 spring wedding dresses was ... designs in this collection, and all of them are ... promises to provide the most fashionable designs to ... fashion trends come and go. If ladies have any ... is ready to assist. , “These new models ...
(Date:12/21/2014)... Recently, one of the best prom dresses online shops ... introduced its new collection of 2015 prom dresses, and ... its prom dresses & other fashionable designs, up to ... quality dress products and great customer services to its ... the best prom dresses online shops around the world ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Serious Buyer, ... for Vintage 1967 Jm Morrison and the Doors International Ballroom ... This would also be the only time that Morrison's ... was on Nov. 25, 1967. According to Hawley, “This ... They did play the Alexandria Roller Rink earlier that ...
(Date:12/21/2014)... 2014 SCI explores disability ... and systemic barriers for disabled athletes with Aaron ... has a condition called juvenile macular degeneration, where he ... he adapted his athletic ambitions to his vision and ... triathlon to pioneer the way for other blind and ...
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at the ... its kind, the site has provided its faithful users with ... running. It uniquely combines the benefits of platforms like ... to the masses. Assuring the potent herb’s followers it’s ... public approval. , Shane Chattin, Owner of Cannabis ...
Breaking Medicine News(10 mins):Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2
... April 23 President,George W. Bush personally recognized ... Quality Award at a private event at the ... organizations in the country,and the only one in ... highest Presidential honor for quality and organizational,performance excellence., ...
... for future research , , WEDNESDAY, April 23 (HealthDay News) ... Alzheimer,s disease appears to hasten progress of a related ... a new study. , The surprising findings, published in ... of Clinical Investigation , are significant, because individuals with ...
... April 23 NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ... and hospitals throughout the United States,today announced that it ... at 4:30 p.m. (EDT) with management to review the ... Web Cast, A live and archived webcast will ...
... and Mikulski to quickly pass,companion bill and send measure ... the,supporters and cosponsors of the Protecting the Medicaid Safety ... House of Representatives. The bill,prevents massive increases in costs ... the administration., "Today,s vote is a victory for ...
... oversulfated chondroitin sulphate caused deaths, reactions , , WEDNESDAY, April ... that lots of the blood thinner heparin pulled from ... oversulfated chondroitin sulfate. , The findings were published ... according to a paper published online simultaneously in the ...
... leaders are,rediscovering the importance of strong competitive intelligence ... today,s economic,environment, according to a new study by ... -- Competitive Intelligence adds value and gains,buy-in through ... actionable insights that have a financial impact for ...
Cached Medicine News:Health News:President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House 2Health News:Enzyme Beneficial to Alzheimer's Plays Darker Role in Other Dementia 2Health News:NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss First Quarter 2008 Earnings Results 2Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2Health News:Researchers Identify Contaminant in Tainted Heparin 2Health News:Researchers Identify Contaminant in Tainted Heparin 3Health News:Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: